Prenatal exposure to ‘forever chemicals' may raise blood pressure during teen years: Study
Humans exposed to toxic 'forever chemicals' before birth may exhibit higher blood pressure during their teenage years, a new study has found.
This connection was particularly pronounced in boys and in children born to non-Hispanic Black mothers, scientists observed in the study, published on Thursday in the Journal of the American Heart Association.
While previous research has shown that these synthetic compounds may affect a rapidly developing fetus, the new study was able to investigate impacts on blood pressure from early childhood through adolescence.
'This suggests these forever chemicals can have long-lasting and potentially harmful effects that may only become apparent years after birth,' lead author Zeyu Li, a graduate student researcher in public health at Johns Hopkins University, said in a statement.
Forever chemicals, or per- and polyfluoroalkyl substances (PFAS), have been linked to numerous illnesses, such as kidney cancer, testicular cancer, thyroid disease, cardiovascular conditions and preeclampsia — also a blood pressure issue.
Notorious for their inability to break down in the environment, PFAS are present in a wide range of household products, including cosmetics, waterproof apparel and nonstick pans, as well as in certain kinds of firefighting foams.
To draw their conclusions, the study authors tracked 1,094 children from a group called the Boston Birth Cohort over a median span of about 12 years.
The researchers analyzed more than 13,000 blood pressure readings taken at routine pediatric visits from July 2001 to February 2024, grouping the results into age brackets of 3-5, 6-12 and 13-18.
They then calculated age-, sex- and height-specific blood pressure percentiles, while accounting for the mother's health, delivery method, socioeconomic factors and weekly fish consumption, as fish are a known source of PFAS contamination.
Among the children whose mothers had higher levels of the chemicals in blood samples collected after delivery, the scientists identified issues with three types of PFAS: PFDeA, PFNA and PFUnA.
As levels of these PFAS doubled in the moms, systolic blood pressure — the top number in a reading, or the pressure in the arteries when the heart contracts — were between 1.39 and 2.78 percentile points higher in the 13 to 18-year-old age group.
Under these conditions, diastolic pressure — the bottom number, or the pressure when the heart muscle relaxes between beats — surged 1.22 to 2.54 percentile points higher among members of this cohort.
With the doubling of maternal PFAS blood levels, the risk of elevated blood pressure rose by 6 to 8 percent in boys and in children born to non-Hispanic Black mothers, according to the study.
Li expressed hope that due to the study's findings, more researchers might be inspired to track such effects in children into adolescence.
'Many past studies stopped at early or mid-childhood, however, our study shows that the health effects of prenatal PFAS exposure may not appear until the teen years,' Li said.
Senior author Mingyu Zhang, an assistant professor at Beth Israel Deaconess Medical Center and Harvard Medical School, stressed that reducing prenatal and childhood exposure to PFAS requires policy-level action, as well as product phase-outs and widespread water regulation.
'This is not something individuals can solve on their own,' Zhang added.
Justin Zachariah, an associate professor at Baylor College of Medicine who was not involved with the study, explained that PFAS interfere with hormones and disrupt typical adolescent development.
While scientists are already aware that boys and Black children are at increased risk of elevated blood pressure, exposure to these compounds may exacerbate that risk, warned Zachariah, who also chaired the American Heart Association's 2024 scientific panel on pediatric cardiology and environmental exposures.
'These chemicals last in our bodies for years, suggesting that perhaps prenatal exposure may have occurred before conception, and these chemicals may cause changes that can carry forward for generations,' Zachariah said.
'Therefore, improvements we make could echo for generations to come,' he added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 days ago
- Boston Globe
Mass. Black therapists trying to diversify the workforce face an uphill battle
Advertisement 'We took the good and left the bad, and helped create this,' Labissiere, one of the clinic's cofounders, said from the Hyde Park Avenue office. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Labissiere and Wynn are rarities in this grueling industry: Black clinicians who have stuck around and own their own practice. The Child and Family Wellness Center isone of just a few Black-owned behavioral health practices in Massachusetts. In interviews with the Globe, 10 Black mental health care providers, advocates, and public officials agreed several systemic barriers keep the workforce from diversifying. The deep-seated stigma of mental illness among Black people, the time and financial costs of finishing school, and the biases embedded in the field's license exams are roadblocks for diversifying the workforce, which already suffers from massive turnover and vacancy rates. Related : Advertisement The societal costs are immense. The experienced these symptoms at higher rates, said Gemima St. Louis, vice president for workforce initiatives and specialty training and clinical psychology professor at Williams James College in Newton. As the mental health crises that COVID-19 drew out persist, stakeholders worry the behavioral health workforce won't be able to meet this rising demand with culturally competent care. 'We have a workforce that is insufficient, a workforce that lacks the diversity that is represented in the communities that have the greatest needs for mental health services,' St. Louis said. Related : Advocates are introducing measures to tackle the representation gap at its root. Clinicians working in underserved communities can have some of their student debt covered through The people working to diversify the behavioral health workforce are chipping away at a profession that has historically been for white and affluent individuals. A 2023 Advertisement One in 10 respondents in behavioral health leadership roles identified as non-Hispanic Black. Black respondents made up 9 percent of the survey's independently licensed clinicians, meaning they don't need supervision to provide treatment. Only 7.6 percent of behavioral health physicians — professionals with medical degrees — were Black. The lack of representation within the sector doesn't match the range of people needing these services, advocates say. A separate survey of insured residents across Massachusetts found that one in 10 non-Hispanic Black residents reported poor mental health in 2021, along with 15 percent of Hispanic residents. One barrier driving these disparities precedes any roadblocks Black clinicians are facing in their field: mental health care's taboo nature in their community. Black people 'might have a little bit more wealth and more opportunities, but we've never really had a chance to really process our struggles in this country,' said Nieisha Deed, founder of Recruitment into the sector can be happenstance, instead of something instilled from an early age. Larry Higginbottom, CEO of The Osiris Group clinic in Roxbury, stumbled across 'the mental health field' during a chance conversation in the late '80s with Omar Reid, a local pioneer of Black psychology and mental health. Advertisement It was a foreign concept, but '[Reed] planted a seed,' Higginbottom, now 71, said. For Melanie Robinson Findlay, owner of Upwards 'N' Onwards, an independent therapy practice in Hyde Park, the death of a best friend during high school propelled her into social work. By the time she pursued a doctorate, she had 18 years of clinical social work experience, completed a clerkship, and was even appointed to the state's Board of Registration of Social Workers. But this didn't seem like enough. She noticed her peers would find supervisors with ease. Meanwhile, 'I always felt I had to prove myself.' 'What was I missing that they have?' Robinson Findlay said. 'And when you control for all the things, there's only one thing that pops out.' Learning about the craft is only the first hurdle to entering the industry. It costs hundreds for Mental health counselors, clinical social workers, psychologists, and other professionals within the field must complete thousands of hours to qualify for a license, some of which have to be under direct supervision from another practitioner. Labissiere said the onus for supervision is placed on the aspiring clinician; they must find someone who is willing to sign off on their application and in turn, lose an employee that keeps their own practice afloat. 'These are gatekeeper positions,' Labissiere said. 'If you don't have an organization ... pushing you to become licensed, we get stuck.' Advertisement Wynn worries this mentality might choke off the next generation of clinicians of color, which is already a small group. 'People look at it as competition, but there's more than enough clients in need,' Wynn said. 'It's not a competition. It's a collaboration.' While navigating the many stressors of entering the workforce, many aspiring social workers aren't taught the financial literacy needed to start and sustain independent practices, said Malaka Mims, president of the Greater Boston Association of Black Social Workers. So many social workers are focused on passing the exam, she said, that they often say, 'I don't know how to be a business owner.' 'Social workers are trained to help others, but the field must also prioritize self care and equip social workers to care for ourselves,' Mims said. For Robinson Findlay, of Upwards 'N' Onwards, running her own practice has been a longtime dream, but it comes with its own challenges. She has scaled her fees down to accommodate low-income clients, and says she is owed thousands in private insurance reimbursements. She makes up with consulting, lecturing, and a postdoctoral fellowship. Robinson Findlay can barely afford to do this, but she can't refuse a client's request. 'Even if I say no to one, that's too many.' This story was produced by the Globe's team, which covers the racial wealth gap in Greater Boston. You can sign up for the newsletter . Tiana Woodard can be reached at
Yahoo
2 days ago
- Yahoo
LevelJump Announces 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - June 20, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2024. Financial and Operational Highlights Revenues were $17.7 million in 2024 compared to $12.6 million in revenues for 2023, a year over year revenue increase of 41%. Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for 2024 of $3.35 million. 2024 Financial Results for fourth quarter and year Revenues of $4.8 million in Q4 2024 and $17.7 million for the year 2024 with a net profit of $1.95 million for Q4 2024 and a net profit of $1.2 million for the year 2024. EBITDA of $395,936 for Q4 2024 and $1,545,298 for the year 2024. Subsequent Events Subsequent to the year end, the Company entered an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025. Management Comments "2024 was a transformative year for our Company, marked by significant growth, particularly within our clinic operations," said Mitch Geisler, CEO. "Our year-over-year revenue increased by more than 40%, and we achieved strong EBITDA performance. We are now interpreting imaging scans for approximately 200,000 patients annually across all operations. Our focus remains on driving organic growth and advancing our long-term vision for continued expansion." Non-IFRS Financial Measures This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity. For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website ( and under the Company's profile on SEDAR+ ( About LevelJump Healthcare LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve. ON BEHALF OF THE BOARD OF DIRECTORS OFLEVELJUMP HEALTHCARE CORP. Mitchell GeislerChief Executive Officerinfo@ CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable). Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Drinking water map shows where toxic ‘forever chemicals' are found in the UK
Traces of a chemical that researchers fear could harm human reproduction have been found in dozens of Britain's rivers, a new study has warned. Researchers from York University found trifluoroacetic acid (TFA) in 98% of locations in 32 rivers in England, Wales, Scotland and Northern Ireland. TFA is one of a family of more than 14,000 man-made chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAs), which have been used since the 1940s in everything from waterproof clothing to non-stick frying pans, as well as cosmetics and food packaging. The chemicals can accumulate in people's bodies (as well as in the water we drink) and can lead to serious health issues including cancer, liver damage and harm to unborn children. The UK government launched an inquiry this year into the issue - but campaigners say not enough is being done. Natalie Sims, from the Royal Society of Chemistry, told Yahoo News: 'There is more that could be being done, and that is why we are calling for action.' The Royal Society of Chemistry has mapped levels of the chemicals in Britain's drinking waters, and is calling for the public to take action to raise the issue. 'The public can be really powerful, and I think we have seen that when we look at tackling sewage overflows, that's really been pushed up the government agenda, because the public is also pushing for it," Sims says. 'That's why we really want to take action now, and that's why there's been much more push for it from organisations like ourselves or others. In addition to developing alternative materials, we urgently need stronger, more robust controls to prevent further pollution and reduce our exposure to harmful substances in the environment.' PFAs are a group of thousands of chemicals that don't occur in nature and are extremely hard to get rid of. They also also toxic, even in small quantities. They have been used in manufacturing and consumer products since the 1940s. 'We've used them so extensively, really since the 1940s they found our way in so many different consumer products," Sims explains. "For example, in your waterproof coat, anything waterproofing, school children's clothing, anything stain resistant. PFAs have some desirable properties, and are so good at what they do in terms of that heat resistance, that water and oil resistance, stain resistance, durability, often a lot of the things that makes it very useful in products. 'Because they're so persistent, they obviously found their way into the environment, into our food, into our water. They are also used in jet engines, medical devices, refrigeration systems, the construction industry and electrical devices. In the environment, they can last for extremely long periods: hundreds or even thousands of years. They also accumulate in human bodies. 'Forever chemicals' have been phased out of some consumer products - but are still used in products such as non-stick frying pans and some packaging, although manufacturers tend to be reluctant to say exactly where they are used. The dangers attached to PFAs often comes when they are used industrially, or when products containing PFAs are disposed of inadequately, meaning they enter the water supply. In the UK, PFAs are most likely to be found in water near industrial sites including airports and areas that produce products which use PFAs. The Royal Society of Chemistry warns that contamination is likely near landfill sites where liquid contaminated with PFAs can leak out of the site, or near incinerators which often are not hot enough to fully burn chemicals can also be found near where firefighting foam is routinely used, including airports, military sites and fire-training areas. Some airports, including Heathrow, have already switched to using foam which does not contain PFAs. Wastewater sites can also leech PFAs into the water. The chemicals have been linked to serious health issues including liver damage, some cancers and harm to unborn children, thyroid disease and fertility issues. Large-scale studies have shown that PFAs in drinking water correlates with increased levels of cancer in multiple parts of the body. A review in the journal eBioMedicine linked PFAs exposure to decreased efficiency in vaccines, premature birth, increased severity of COVID-19, along with cancer, reduced immune function and developmental delays in children. Water companies in England and Wales must monitor and regulate 48 types of PFAs, despite there being thousands of varieties, with many remaining untested. But this Drinking Water Inspectorate ruling actually goes further than EU legislation. Individual PFAs concentrations in drinking water cannot exceed 100 nanograms per litre (ng/L). This is 10 times higher than the Drinking Water Inspectorate's own 'low risk' threshold of 10 ng/L. In the US, there are limits of 4 ng/L for each of PFOS and PFOA, two of the most common PFAs, and the EU states that 20 widespread PFAs must collectively not exceed 100 ng/L. The Royal Society of Chemistry has called for new limits on the amounts of PFAs permissible in drinking water. Specifically the RSC has called for a new limit of 10 ng/L for individual PFAs. The RSC has also called for stricter controls over the sources of PFAs including in industrial discharges, with a national chemicals regulator to monitor and regulate discharges. Sims says: 'An RSC survey of more than 4,000 UK adults, carried out by YouGov in August showed nine in ten Britons believe it's 'very important' to keep PFAS out of our food, water and environment. The public do want action on this, which I think is really powerful when it comes to speaking to the government. 'In terms of industry, having them push to develop alternatives, because they've had these chemicals that they've been allowed to use for so long, in terms of because they're so good at what they do, it's trying to transition that away into more, safer and sort of sustainable alternatives. Sims says that it's also vital that British people have a clearer picture of the chemicals in the water they drink. She says: 'PFAS are contained in many products and ingredients that are made or imported to the UK for use across many industries. However, we do not have a full picture of how PFAS enter and move within the supply chain. 'It's likely that the exposure you have on the everyday is going to be quite low, but it's that long term build up where, for one thing, it can be really challenging to pinpoint where those adverse effects could come from.'
